Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mouth feel may explain why cancer patients stop eating

NCT ID NCT05272917

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how head and neck cancer patients sense texture, temperature, and spice in their mouths after treatment. Researchers compared 72 patients to healthy volunteers using touch tests and food preference questionnaires. The goal was to understand if changes in mouth sensation affect eating habits and nutrition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help design better dietary support for head and neck cancer patients by understanding how their sense of touch in the mouth affects eating.
What could go wrong
This is a small, completed observational study with only 72 participants. It does not test a treatment, so it cannot directly improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

May 2022

Finished

Apr 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: All subjects: * Person between 18 and 65 years * Person having given free, informed, express written consent * Person affiliated to a French social security system * Person with a body mass superior to 18 kg/m². * Person able to come once to the Institut Paul Bocuse Patients with head and neck cancer with chemotherapy: \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone Patients with head and neck cancer without chemotherapy: \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone Healthy volunteers : * Volunteer who is +/- 5 years of age relative to the patient to whom they are matched. * Volunteer of the same sex as the patient to whom they are matched * Volunteer with the same smoking status as the patient to whom they are matched * Volunteer who has not had cancer within 5 years at the time of inclusion * Volunteer with no current treatment that may affect taste and smell perception Exclusion Criteria: All subjects: * Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly) * Person with a known allergy to chili (or capsaicin) * Person with diagnosed total ageusia * Person with diagnosed total anosmia * Person who has used artificial feeding within 2 months prior to inclusion. * Person who has lost more than 10% of baseline weight in the 2 months prior to inclusion * Person deprived of liberty or under guardianship or trusteeship. * Pregnant or breastfeeding woman * Person deprived of liberty by a judicial or administrative decision * Person under guardianship or protection of vulnerable adults * Person with trismus (reduced jaw opening or limited jaw range of motion) * A person who is unable to extend his or her tongue * Person who has had surgery on the mobile tongue and/or base of the tongue * Person unable to swallow soft foods * Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months. Patients with head and neck cancer: * Patient receiving immunotherapy * Patient treated with surgery only.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre de recherche de l'Institut Paul Bocuse

    Écully, 69131, France

  • Service d'Oncologie médicale, Hôpital de la Croix-Rousse

    Lyon, 69004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.